With an impact factor of 20.3, Blood is the most cited peer-reviewed publication in the field of hematology. It provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology.
With an impact factor of 7.6, Blood Advances publishes more peer-reviewed hematology research than any other academic journal worldwide. It is an online-only, open access journal that publishes new content continuously, including original research and important community resources such as the ASH Clinical Guidelines.
Blood Neoplasia is an online-only, open access journal publishing research focused on hematologic malignancies and associated disorders, including leukemia, lymphoma, multiple myeloma, Waldenström macroglobulinemia, hemophagocytic lymphohistiocytosis, myeloproliferative neoplasms, minimal residual disease, and precursor conditions. New content is published continuously.
Blood Vessels, Thrombosis, and Hemostasis (Blood VTH) is an online-only, open access journal publishing research focused on thrombosis, hemostasis, and vascular biology, as well as associated disorders, including hemorrhagic disorders and platelet blood disorders. New content is published continuously.
